- Report
- February 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- February 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- January 2024
- 200 Pages
Global
From €3861EUR$4,000USD£3,312GBP
- Report
- March 2024
- 149 Pages
Global
From €2895EUR$2,999USD£2,483GBP
- Report
- January 2024
- 150 Pages
Global
From €4681EUR$4,850USD£4,016GBP
- Report
- April 2024
- 187 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- January 2024
- 182 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- October 2023
- 171 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- August 2023
- 114 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- February 2024
- 110 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 120 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 90 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- July 2023
- 225 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- January 2024
- 200 Pages
Global
From €4006EUR$4,150USD£3,436GBP
- Report
- October 2023
- 85 Pages
United States
From €4585EUR$4,750USD£3,933GBP
- Report
- July 2023
- 89 Pages
Middle East
From €4247EUR$4,400USD£3,643GBP
- Report
- June 2020
- 464 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- December 2019
- 381 Pages
Global
From €4342EUR$4,499USD£3,725GBP
- Report
- January 2022
- 234 Pages
Global
From €5067EUR$5,250USD£4,347GBP
- Report
- December 2022
- 425 Pages
Global
From €4766EUR$5,111USD£3,950GBP
The genotyping market is a subset of the genomics industry that focuses on the identification of genetic variations between individuals. It is used to identify genetic markers associated with diseases, to determine the risk of developing certain conditions, and to identify the most effective treatments for a given individual. Genotyping is also used in the development of personalized medicine, which is tailored to the individual’s genetic makeup. Genotyping technologies include next-generation sequencing, microarrays, and PCR-based methods.
The genotyping market is expected to grow due to the increasing demand for personalized medicine, the development of new technologies, and the increasing availability of genomic data. Additionally, the increasing prevalence of chronic diseases and the need for more accurate diagnosis and treatment are expected to drive the growth of the genotyping market.
Some companies in the genotyping market include Illumina, Thermo Fisher Scientific, BGI, Agilent Technologies, and PerkinElmer. Show Less Read more